Ignite Creation Date:
2024-05-05 @ 9:57 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001020
Status:
COMPLETED
Last Update Posted:
2012-05-18
First Post:
1999-11-02
Brief Title:
A Phase I Study of the Safety and Immunogenicity of rgp120HIV-1IIIB Vaccine in Healthy Adult Subjects NOTE Study Extended ONLY for Subjects Who Have Previously Received rgp120HIV-1IIIB or rgp120HIV-1MN on VEU 006 or VEU 006 Rollover Study
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID